Eiger BioPharmaceuticals, Inc. (EIGRQ) vs Windtree Therapeutics, Inc. (WINT)
Eiger BioPharmaceuticals, Inc. and Windtree Therapeutics, Inc. are both Biotechnology companies. Eiger BioPharmaceuticals, Inc. and Windtree Therapeutics, Inc. are of similar size ($2.6M and $2.4M). Eiger BioPharmaceuticals, Inc. grew revenue faster over the last twelve months: 17.0% against −68.4%. Windtree Therapeutics, Inc. has the higher net margin (0.00% vs −475.3%) and the higher return on invested capital (−386.3% vs −3,674.6%). Across the 15 metrics below, Windtree Therapeutics, Inc. leads on 8 and Eiger BioPharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | EIGRQ | WINT | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.85% | 0.00% | 65.16% |
| Operating margin | (455.12%) | 0.00% | 0.00% |
| Net margin | (475.26%) | 0.00% | 0.00% |
| Free cash flow margin | (474.11%) | 0.00% | 0.00% |
| Return on equity | (367.00%) | 1,356.23% | (57.72%) |
| Return on assets | (94.31%) | (210.34%) | (49.22%) |
| Return on invested capital | (3,674.55%) | (386.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack